Effects of Anemarrhena asphodeloides on Focal Ischemic Brain Injury Induced by Middle Cerebral Artery Occlusion in Rats
) of the analysis of interest and production of characteristic fragment ions. The following instrumental parameters were used for APCI-MS detection of anemarsaponin B in the positive ion mode; capillary, 3.5 kV; cone, 40 V; hex 1, 20 V; aperture, 0 V; hex 2, 0 V; source temperature, 100°C; desolation temperature, 500°C; desolation gas, 600 l/h; cone gas, 40 l/h; low mass resolution, 15.0; high mass resolution, 15.0; ion energy, 0.5; multiplier, 650.
Transient Focal Cerebral Ischemia Animals were anesthetized in a chamber with a mixture of N 2 O and O 2 (70 : 30) containing 2.5% isoflurane. The middle cerebral artery (MCA) was occluded as described by Nagasawa and Kogure, 15) with minor modifications. Briefly, after making a median incision in the neck skin, the right common carotid artery was exposed and a 17-mm-long 4-0 nylon thread with a rounded tip (coated with silicon) inserted from the bifurcation to the right MCA. After surgery, rats were allowed to recover from the anesthesia. Two hours after MCA occlusion (MCAO), the thread was removed to allow complete reperfusion of the ischemic area under re-anesthesia. Neurological deficits characterized by severe left-sided hemiparesis and right Horner's syndrome were used as criteria to evaluate the ischemic insult. Rats that did not exhibit behavioral deficits before reperfusion were excluded from the study. Heart rate, arterial blood oxygen saturation of arterial hemoglobin, and ECG were monitored throughout the procedure (SurgiVet, U.S.A.). Body temperature was maintained at 37Ϯ0.5°C throughout surgery by a heating pad (Biomed S.L., Spain).
Drug Administration Rats that showed positive neurological signs 2 h after MCAO were randomly divided into control, MCI-186, and WEAA treated groups. For dose-response studies, WEAA (50, 100, 200, 400 mg/kg) was dissolved in saline and orally administered promptly prior to reperfusion and again 2 h later. Rats in the control group were given saline orally and rats in the positive control group were given MCI-186 (10 mg/kg, p.o.) using the same time schedule used in the WEAA treated group. To evaluate the therapeutic time window of WEAA, double treatments of 200 mg/kg (p.o.) with a 2 h interval were performed at 0.5 h and 2.5 h, 1 h and 3 h, 2 h and 4 h, and 3 h and 5 h after MCA occlusion.
Morphometric Measurement of Infarct Volume and Edema The area of cerebral infarction was identified by TTC staining. After reperfusion for 22 h, animals were decapitated and their brains carefully removed. The brains were sectioned coronally with a brain slicer at 2-mm intervals, starting 1 mm from the frontal pole. Slices were incubated for 60 min in a 2% solution of TTC at 37°C and fixed by immersion in 10% neutral-buffered formalin. The area of infarction (mm 2 ) of each section was determined by computerized image analysis system (TDI Scope Eye 3.0), and the total lesion volume (mm 3 ) was calculated by summing the infarct area in each section (seven slices in all) and multiplying this by the distance between sections. Both contralateral and ipsilateral hemisphere areas were measured, and the differences between the two areas were used to calculate the edema volume.
Measurement of MPO Activity MPO activity in brain tissue was determined as an index of neutrophil accumulation, as previously described. 16) In brief, brains were rapidly removed and cut into two 4-mm thick slices (3 to 7 mm and 7 to 11 mm from the frontal pole), and then separated into right and left hemispheres. Wet weights were immediately recorded. Each sample was homogenized in 20 wt/vol of 50 mM potassium phosphate buffer (pH 6.0) and centrifuged at 30000 g (30 min, 4°C). The supernatants were discarded, and the pellets suspended in 0.5% HTAB in 50 mM potassium phosphate buffer (pH 6.0) at an original tissue wet weightto-volume ratio of 1 : 10. Samples were then immediately frozen on dry ice, and three freeze/thaw cycles were performed with sonication (10 s, 25°C) between cycles. After the final sonication, samples were incubated at 4°C for 20 min and centrifuged at 12500 g (15 min, 4°C). The supernatant so obtained (0.05 ml) was mixed with 0.95 ml of potassium phosphate buffer (pH 6.0) containing 0.167 mg/ml of O-dianisidine and 0.0005% hydrogen peroxide. Change of absorbance at 460 nm was measured by spectrophotometer equipped with a kinetic analysis capability (JASCO, Japan). One unit of MPO activity was defined as the amount that degraded 1 mmol of peroxide/min at 25°C. Tissue MPO activity was calculated using human MPO as standard.
MPO Immunohistochemistry Rats treated with vehicle or WEAA (200 mg/kg) were anesthetized with pentobarbital sodium (60 mg/kg, i.p.) and perfused transcardially with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). Brains were removed and postfixed in the same fixative solution overnight and subsequently cryoprotected with 20% sucrose in 0.05 M phosphate-buffered saline (PBS, pH 7.4) for 48 h. Thereafter, 40-mm sections were prepared in the coronal plane using a cryostat.
Free floating sections were incubated for 24 h in PBS (4°C) containing anti-MPO antibody (1 : 500), 0.3% Triton X-100, 0.5 mg/ml of bovine serum albumin, and 1.5% normal horse serum. The sections were then incubated with biotinylated secondary antibody (1 : 200) for 90 min then with avidin-biotin-peroxidase complex (1 : 100) at room temperature for 1 h. The peroxidase was reacted with 0.02% 3,3Ј-diaminobenzidine and 0.01% H 2 O 2 for about 5 min. After each incubation step, sections were washed three times with PBS.
DPPH Radical Scavenging Assay Free radical scavenging ability was determined using the stable DPPH dissolved in aqueous methanol. Various concentrations of 0.1 ml of sample solution were added to 1.9 ml of the DPPH radical solution (0.1 mM). After incubation at 25°C for 30 min, absorbance was measured at 515 nm. The percentages of the DPPH radical remaining were calculated by comparing the absorbance between the sample and the control. A control solution consisted of 0.1 ml of aqueous methanol and 2.0 ml of DPPH radical solution. (Ϫ)-Epicatechin was used as positive control.
Statistical Analysis Values are expressed as meansϮ S.E.M. Statistical analysis was carried out using one-way analysis of variance (ANOVA) followed by Duncan's multiple range test for drug-treated groups versus control (vehicletreated) group. Statistical significance was set at pϽ0.05. Student's t-test was used to compare MPO activity with that of the control group.
RESULTS
Standardization of WEAA Quality control of WEAA was performed using anemarsaponin B isolated from dried A. asphodeloides. In this system, anemarsaponin B was detected at around 11.1 min (Fig. 1) . The contents of anemarsaponin B in WEAA were 2.41Ϯ0.37% (nϭ5).
Neuroprotective Effects of WEAA MCA occlusion for 2 h followed by 22 h of reperfusion resulted in extensive and reproducible focal infarction and hemispheric swelling throughout the cortical and subcortical structures, as quantified 24 h after MCA occlusion. A large infarct was induced in 2-h ischemia/22-h reperfusion control animals as shown in Fig. 2 (total infarct volume was 346.35Ϯ14.44 mm 3 ). In the WEAA-treated group, the ischemic areas unstained by TTC staining were located mainly in the lateral part of the striatum and the surrounding cortical areas, which constitute the core of the infarct. The anterior and medial parts of the striatum and large areas of the cortex remained unaffected compared with the control group. Total infarct volumes in the ipsilateral hemisphere of ischemia-reperfusion rat were significantly reduced by WEAA treatment in a dose-dependent manner (Fig. 2) . Total infarct volumes at doses of 50, 100, 200, and 400 mg/kg were reduced approximately by 8%, 29%, 48%, and 49%, respectively, versus the control group. Maximal protective effects of WEAA on ischemia were achieved at 200 and 400 mg/kg; no significant difference was observed between the 200 and 400 mg/kg treated groups. Moreover, treatment with MCI-186 (10 mg/kg, p.o.) reduced the infarct volume by 47%. Cerebral edema also occurs commonly during the acute phase of a large cerebral infarction, and we found that administration of WEAA after MCA occlusion significantly reduced brain edema in a dose-dependent manner. Brain edema in the control group was 13.99Ϯ 0.74% at 24 h after ischemic injury. And, brain edema at doses of 50, 100, 200, and 400 mg/kg of WEAA was reduced by 2%, 14%, 37%, and 46%, respectively, compared with the control group. Therapeutic Time Window of WEAA WEAA (200 mg/kg, p.o.) was administered at 0.5 h and 2.5 h, 1 h and 3 h, 2 h and 4 h, and at 3 h and 5 h after MCA occlusion, and significantly reduced infarct volumes by 53%, 52%, 48%, and 28%, respectively, compared with the control group (Fig. 3) . Brain edema at 0.5 h and 2.5 h, 1 h and 3 h, 2 h and 4 h, and 3 h and 5 h after MCA occlusion was also reduced approximately by 50%, 42%, 38%, and 4%, respectively, versus control. Brain edema tended to be smaller when treatment started 3 h and 5 h after MCAO, but this was not statistically significant. These data indicate that the optimal therapeutic time for WEAA administration was 3 h in this ischemiareperfusion rat model. Figure 4 illustrates MPO activity in the MCA territory in response to MCA occlusion. In the control group, MPO activity in the ipsilateral hemispheres (0.367Ϯ0.002 unit/g wet tissue) was significantly greater than that in the contralateral hemispheres. In rats given WEAA, mean MPO activity in the ipsilateral hemispheres (0.216Ϯ0.003 unit/g wet tissue) was significantly lower than that observed in the control group (pϽ0.001).
Effects on MPO Activities
MPO Immunohistochemistry Analysis MPO-positive cells were analyzed in the striatum (0.2 mm posterior to bregma) and cortex (3.6 mm posterior to bregma). In the sham group, almost no MPO-positive cells were identified in the striatal and cortical areas, and in the WEAA treatment group only minimal MPO-positive cells were observed in these areas 24 h after MCAO (Fig. 5) . However, in marked contrast, the brains of control rats studied at 24 h contained dramatic accumulations of MPO-positive cells within pial and parenchymal blood vessels and within the cortical and subcortical parenchyma. MPO-positivity was most robust in areas of severe injury, and greater in the cortical regions than in the striatum (Fig. 5) .
DPPH Radical-Scavenging Activity The antioxidant activities of WEAA were assessed on the basis of the radical scavenging effect of the stable DPPH free radical. (Ϫ)-Epicatechin, which was used as reference standard, exerted the highest antioxidant activity and possessed significant free radical-scavenging properties (over 95% inhibition of DPPH), whereas WEAA was relatively inactive (only 16.4% inhibition) at a concentration of 1 mg/ml (Table 1) .
DISCUSSION
In this study, we investigated whether treatment with WEAA can protect rat brain from injury induced by transient focal cerebral ischemia. We found that both ischemia-reperfusion-induced infarct volume and edema were reduced by WEAA in a dose-dependent manner, and that MPO activity was suppressed significantly in post-ischemic brain tissue.
A. asphodeloides, which is widely used in traditional Chinese medicine, is known to have anti-diabetic, anti-platelet aggregation, and diuretic activity, and various steroidal saponins have been isolated from A. asphodeloides. 11, 12) Among these, timosaponin A-III and markogenin glycoside have been reported to inhibit ADP-, 5-HT-, and arachidonic acid-induced aggregation of human platelets.
12) Kaname et al. 17) also reported that timosaponin E1 and E2 inhibit platelet aggregation and delay activated partial thromboplastin time in a concentration-dependent manner. Moreover, anemarsaponin B was reported to have inhibitory activity against platelet aggregation induced by platelet activating factor (PAF) in vitro. 18) These results suggest that steroidal saponins from A. asphodeloides might be useful as novel antithrombotic therapeutic agents post-myocardial infarction. 13) However, no study has been undertaken on the neuroprotective effects of A. asphodeloides in ischemic brain damage.
WEAA was found to have a significant neuroprotective effect after double treatment in this rat reperfusion model, approaching 48% at 22 h similar to that of MCI-186 as positive control. MCI-186 has been reported to have neuroprotective effects in both hemispheric embolization and transient cerebral ischemia in rats. [19] [20] [21] In addition, post-treatment with WEAA delayed for 2 and 4 or 3 and 5 h after ischemia significantly prevented the progression of infarction after MCAO. The time between onset of ischemia and initiation of drug treatment is a critical factor in treating acute ischemic stroke: our results obtained by the study of therapeutic time window support the usefulness of WEAA in treating acute ischemic stroke.
In animals treated with WEAA only minimal numbers of MPO-positive cells were present at 24 h after MCAO, whereas in marked contrast the brains of control rats contained dramatic accumulations of MPO-positive cells both within pial and parenchymal blood vessels and within the striatum and cortex areas. In the sham group, almost no MPO-positive cells were observed in the striatum and cortex areas (data not shown). However, WEAA did not show significant free radical scavenging properties (only 16.4% inhibition of DPPH). Since inhibition of MPO activity plays a more critical role in injured brain tissue than DPPH radicalscavenging activity, it appears that the reduced brain infarct volume due to WEAA treatment is more likely due to reduced neutrophil infiltration. Analysis of the infarct volume and MPO activity data demonstrated a clear correlation between reduction of brain infarct volume and MPO activity of injured tissue rather than with DPPH radical-scavenging activity. However, it is difficult to exclude the involvement of radical scavenging effects because higher concentrations of WEAA inhibited DPPH radicals and protected neuronal cell death in rat hippocampal slices in culture deprived of oxygen and glucose (data not shown).
Using MCAO model, Chopp et al. 22) showed that treating rats with anti-Mac-1 antibodies also significantly reduced neutrophil accumulation in the ischemic cortex and subcortex. Furthermore, Matsuo et al. 6) reported reductions in the level of cortical and striatal neutrophils when ischemic rats were pretreated with an anti-neutrophil monoclonal antibody. Both studies showed a positive correlation between reduced neutrophil infiltration and the subsequently reduced ischemic injury. Recently, several reports suggest that PAF enhances presynaptic synthesis and release of glutamate in neuronal cultures and PAF-induced neurotoxicity involves the NMDA receptor/nitric oxide signal pathway. 23, 24) It has also been shown that PAF receptor antagonists markedly prevent tissue injury and infarct volume in ischemic states. 25, 26) Dong and Han 18) reported that anemarsaponin B isolated from A. asphodeloides inhibits platelet aggregation. As shown in the Materials and Methods section, anemarsaponin B is contained in high amounts in the extract of A. asphodeloides. If anemarsaponin B acts as a PAF antagonist and an active compound in WEAA, the neuroprotective effect of WEAA on ischemia-reperfusion-induced brain injury can be mediated by PAF inhibition. Unfortunately, more detailed examinations could not be undertaken because the amounts of anemarsaponin B available were insufficient to study the neuroprotective effect in rat MCAO model. Although the precise mechanism of the mode of action of WEAA and an active compound were not elucidated in the present study, it is apparent that the neuroprotective effect is mediated through a reduction of the number of invading neutrophils. Further studies on these issues are required.
In conclusion, the present study demonstrates that WEAA has a neuroprotective effect on ischemia-reperfusion-induced brain injury, and that this agent may act by reducing neutrophil accumulation in brain tissue. Although the action mechanism of WEAA has not been elucidated, it is believed that the anti-ischemic effect of WEAA is mediated via a reduction of neutrophil infiltration into brain tissue. These results suggest that WEAA should be viewed as a lead medicinal herb for the development of neuroprotective agents by providing neuroprotection in transient focal ischemic brain injury. (Ϫ)-Epicatechin was used as a positive control. The data shown are the means of triplicate measurements. (Ϫ)-Epicatechin showed strong activity by eliminating DPPH radicals at a concentration of 1 mg/ml.
